DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
69.23
+1.84 (2.73%)
Apr 15, 2025, 4:00 PM EDT - Market closed
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$391,553
Profits / Employee
$55,942
Market Cap
27.15B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,300 | 700 | 7.29% |
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 316,000 |
Thermo Fisher Scientific | 125,000 |
Medtronic | 95,000 |
AstraZeneca | 92,900 |
Sanofi | 82,878 |
Novartis AG | 75,883 |
Becton, Dickinson and Company | 73,000 |
GSK plc | 68,629 |
DXCM News
- 5 days ago - FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch - Benzinga
- 5 days ago - DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance - Barrons
- 5 days ago - Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System - Business Wire
- 12 days ago - Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time. - Business Wire
- 14 days ago - Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems - Business Wire
- 15 days ago - These 20 worst-performing stocks in the S&P 500 sank 17% or more in March - Market Watch
- 21 days ago - Dexcom Appoints Jon Coleman as Chief Commercial Officer - Business Wire
- 21 days ago - Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom - Business Wire